β‘ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Artielle Immunotherapeutics just got measured.
4/10 means Artielle Immunotherapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Stroke Cancer: Advanced Melanoma Technology Publications Contact Phase I/II Trials Advancing Developing novel therapies for neuroinflammatory diseases Artielle Immunotherapeutics is a venture-backed company pioneering a first-in-class therapeutic platform (DRhQ) to treat neuroinflammatory conditions and advanced cancers β based on groundbreaking research from OHSU and VA Portland Healthcare System
1
Structured Data
5
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
5
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Artielle Immunotherapeutics.
Scored by Engagemii on June 25, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/artielle
Cite this score: Engagemii (2026). "AEO Score for Artielle Immunotherapeutics." Retrieved from https://engagemii.com/aeo/brands/artielle
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform